Measurement of agonist efficacy using an α2A‐adrenoceptor‐Gi1α fusion protein
暂无分享,去创建一个
[1] G. Milligan,et al. Rescue of Functional Interactions between the α2A-Adrenoreceptor and Acylation-resistant Forms of Gi1α by Expressing the Proteins from Chimeric Open Reading Frames* , 1997, The Journal of Biological Chemistry.
[2] G. Milligan,et al. Measurement of agonist-induced guanine nucleotide turnover by the G-protein Gi1alpha when constrained within an alpha2A-adrenoceptor-Gi1alpha fusion protein. , 1997, The Biochemical journal.
[3] M. Scheinin,et al. Gene targeting — homing in on α2-adrenoceptor-subtype function , 1997 .
[4] S. Rees,et al. Interactions of the alpha2A-adrenoceptor with multiple Gi-family G-proteins: studies with pertussis toxin-resistant G-protein mutants. , 1997, The Biochemical journal.
[5] G. Milligan,et al. Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity. , 1996, The Biochemical journal.
[6] G. Milligan,et al. Analysis of inverse agonism at the delta opioid receptor after expression in Rat 1 fibroblasts. , 1996, The Biochemical journal.
[7] R. Graham,et al. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. , 1996, Molecular pharmacology.
[8] G. Guillon,et al. Close association of the alpha subunits of Gq and G11 G proteins with actin filaments in WRK1 cells: relation to G protein-mediated phospholipase C activation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] G. Milligan,et al. Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor. , 1995, Molecular pharmacology.
[10] T. Kenakin,et al. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. , 1995, Trends in pharmacological sciences.
[11] T. Kenakin,et al. Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. , 1995, Trends in pharmacological sciences.
[12] R. Neubig. Membrane organization in G‐protein mechanisms , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] M. Spedding,et al. Alpha 2-adrenoceptors: more subtypes but fewer functional differences. , 1994, Trends in pharmacological sciences.
[14] S. Liggett,et al. Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to Gs. , 1994, Molecular pharmacology.
[15] P. Evans,et al. Agonist‐specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. , 1994, The EMBO journal.
[16] T. Wieland,et al. Measurement of receptor-stimulated guanosine 5'-O-(gamma-thio)triphosphate binding by G proteins. , 1994, Methods in enzymology.
[17] Laurent Journot,et al. Differential signal transduction by five splice variants of the PACAP receptor , 1993, Nature.
[18] D. Hoyer,et al. Partial agonists, full agonists, antagonists: dilemmas of definition. , 1993, Trends in pharmacological sciences.
[19] G. Milligan,et al. Mechanisms of multifunctional signalling by G protein-linked receptors. , 1993, Trends in pharmacological sciences.
[20] Y. Okuma,et al. Immunoprecipitation of alpha 2a-adrenergic receptor-GTP-binding protein complexes using GTP-binding protein selective antisera. Changes in receptor/GTP-binding protein interaction following agonist binding. , 1992, The Journal of biological chemistry.
[21] C. A. Guyer,et al. Cloning, sequencing, and expression of the gene encoding the porcine alpha 2-adrenergic receptor. Allosteric modulation by Na+, H+, and amiloride analogs. , 1990, The Journal of biological chemistry.
[22] M. Rasenick,et al. Tubulin binds specifically to the signal-transducing proteins, Gs alpha and Gi alpha 1. , 1990, The Journal of biological chemistry.
[23] T. Kenakin. Challenges for receptor theory as a tool for drug and drug receptor classification. , 1989, Trends in pharmacological sciences.
[24] G. Milligan,et al. Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins. , 1988, The Biochemical journal.
[25] G. Koski,et al. Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.